HOME >> BIOLOGY >> NEWS
Risk-taking in infertility treatment correlates with women's negative moods

rsus a higher risk option SET versus two embryo transfer (2ET), and 2ET versus three embryo transfer (3ET), and then rating the riskiness of each choice, said Dr. Newton. We found a significant association between womens mood states and their perceptions of the likelihood of a multiple pregnancy. Women estimated their chance of having a multiple pregnancy as lower when they were experiencing more negative moods. When asked to choose between SET and 2ET, women with more negative moods also rated their choices as more risky. One possible explanation is that negative moods lead women to knowingly make more risky choices.

In a follow up study, Dr. Newton and his team plan to determine whether providing women with accurate risk information will influence their decisions about how many embryos to transfer. If infertility patients were to gain a better understanding or the risks and benefits of transferring more or fewer embryos, and the acceptability of SET were to increase, there could be huge benefits, not just emotional and physically to mothers and children, but also in terms of costs to healthcare systems, he said.


'"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
3-Jul-2007


Page: 1 2

Related biology news :

1. Male or female factor infertility -- men suffer just the same
2. New research holds promise for protecting cancer patients against infertility
3. Stressed-out African naked mole-rats may provide clues about human infertility
4. Key to male infertility
5. Researchers find gene mutation that causes infertility in male mice
6. Treating male infertility with stem cells
7. Eating ice cream may help women to conceive, but low-fat dairy foods may increase infertility risk
8. World-first stem cell research could aid male infertility
9. Findings by Einstein scientists reveal possible strategy against obesity, diabetes and infertility
10. Injection may prevent infertility in men receiving cancer chemotherapy
11. Study links high levels of nitric oxide to infertility and sperm DNA damage

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) ... severe COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 ...
(Date:8/21/2020)... ... August 20, 2020 , ... ... Movahhed , a Clinical Operations executive with expertise in clinical trial planning and ... firm as an Expert Consultant. Throughout his career, Mr. Movahhed has helped design ...
(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, ... to announce that Eric Chen and Jessica Wong have joined the company’s leadership ... Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... HOUSTON (PRWEB) , ... August ... ... a biopharmaceutical cold chain validation engineering firm, is making available for ... driving the need to incorporate concurrent transport simulation testing into today’s biologics ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International ... only $3950. With 50 million stem cells total, patients may choose which extremities they ... works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
(Date:7/18/2020)... , ... July 16, 2020 , ... “We are thrilled ... Wave Bioactives. “It’s the only technology of its kind on the market and we ... onions with the protective capacity of traditional cultured ingredients, creating a natural way to ...
Breaking Biology Technology:
Cached News: